Akio Matsuo
Kyoto Prefectural University of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Akio Matsuo.
Cancer | 1980
Hidemoto Ito; Koichi Murakami; Tetsuji Yanagawa; Shinjiro Ban; Hiroji Sawamura; Kisaburo Sakakida; Akio Matsuo; Jiro Imanishi; Tsunataro Kishida
Three patients with pulmonary metastases of osteosarcoma underwent treatment with intravenous or intramuscular administration of human leukocyte interferon. In 2 cases, the size of the metastasized tumor mass diminished temporarily six or eight months after interferon treatment, and serum alkaline phosphatase levels decreased to normal. In 1 case, the tumor cell from the pleural exudate I could be isolated and cultivated in vitro. When 2,000 IU of interferon was added to the tumor cell culture, marked inhibition of tumor cell growth resulted. In the other case, interferon had no effect on the metastasized lung tumor.
Biochemical and Biophysical Research Communications | 1990
Hiroyuki Shirono; Keiko Kono; Junichi Koga; Saburo Hayashi; Akio Matsuo; Hajime Hiratani
Human alpha interferon produced in Sendai virus-stimulated leukocytes was purified by immunosorbent affinity chromatography and subjected to subtype analysis. All subtypes in leukocyte culture supernatant were confirmed in purified preparation. One of these subtypes was reactive in Western blotting with antibody specific to alpha II (omega). N-terminal amino acid sequence analysis of this particular subtype showed addition of two amino acids to the N-terminus of alpha II predicted through cDNA studies. The apparent cleavage site for leader sequence of alpha II was different from the site common to all other alpha subtypes. This is the first report on the isolation of natural alpha II and its unique N-terminal amino acid sequence.
Microbiology and Immunology | 1980
Chin-Bin Pak; Jiro Imanishi; Tsunataro Kishida; Akio Matsuo
Human leukocyte interferon enhanced nitroblue tetrazolium dye (NBT) reduction by human neutrophils (PMNs). Increase in NBT reduction paralleled increase in interferon dose. When human leukocyte interferon was heated to 60 C or 80 C for 30 min, both the antiviral activity and the effect on NBT reduction decreased. Human leukocyte interferon neutralized with anti‐human leukocyte interferon serum showed no effect on NBT reduction. A human fibroblast interferon preparation also enhanced NBT reduction. The species dependency of interferon was shown in NBT reduction as well as in antiviral activity.
Japanese Journal of Microbiology | 1974
Akio Matsuo; Saburo Hayashi; Tsunataro Kishida
Journal of interferon research | 1980
Jiro Imanishi; Toshiro Karaki; Osamu Sasaki; Akio Matsuo; Kinzo Oishi; Chin-Bin Pak; Tsunataro Kishida; Seiya Toda; Hisanori Nagata
Bioscience, Biotechnology, and Biochemistry | 1994
Hiroyuki Shirono; Junichi Koga; Hidetoshi Uemura; Akio Matsuo
Archive | 1990
Junichi Koga; Hiroyuki Shirono; Akio Matsuo; Hajime Hiratani
The Journal of the Japanese Association for Infectious Diseases | 1979
Jiro Imanishi; Kinzo Oishi; Chin-Bin Pak; Tsunataro Kishida; Toshiro Karaki; Osamu Sasaki; Akio Matsuo; Seiya Toda; Hisanori Nagata
The Journal of the Japanese Association for Infectious Diseases | 1979
Jiro Imanishi; Kinzo Oishi; Chin-Bin Pak; Tsunataro Kishida; Toshiro Karaki; Osamu Sasaki; Akio Matsuo; Seiya Toda; Hisanori Nagata
Practica oto-rhino-laryngologica | 1972
Yoshinobu Sato; Masayoshi Tachibana; Osamu Mizukoshi; Akio Matsuo; Tsunataro Kishida